|
The device was not returned for evaluation and no photographic evidence has been provided.Therefore, the reported failure could not be verified and a root cause cannot be determined.Upon gathering additional information, the user facility reported that the patient applied lotion before the procedure.There was no skin preparation prior to pad placement in the user facility.The pad was placed in the patient's outer thigh, parallel to her leg.There were stirrup sterile covers over the reported pad.A review of the manufacturing documents verified the device was produced per current and approved procedures and material specifications.Non-conformances regarding the product's identity, quality, safety, effectiveness or performance were not identified during manufacture.A two-year review of complaint history revealed 3 similar complaints for this product family and failure mode.In that same timeframe, (b)(4) units of this product family have been sold worldwide, making the rate of occurrence of this confirmed failure (b)(4) percent.A risk analysis was performed and found this failure mode and occurrence level to be consistent with current risk documents.The clinical data report for conmed thermogard dispersive electrode determines that under normal conditions of use, undesirable side effects are acceptable when weighed against the benefits to the patients.The instructions for use advises the user of the following.- always use the lowest power setting to achieve the desired surgical effect.- thermogard and thermogard plusabc dispersive electrodes are for use with various patient populations providing there is sufficient surface area to ensure full contact of the pad with the patient's skin.Failure to achieve good skin contact by the entire adhesive surface may result in electrosurgical burns or poor electrosurgical performance.- difficulty in achieving cutting or coagulating energies requires evaluation.Stop.Do not proceed or increase power settings until you have checked all components of the electrosurgical circuit including the active electrode and its cable, the patient, pad adherence and integrity, and the electrical generator and its connectors.- select a well vascularized site in close proximity to the surgical site.Avoid placement on bony prominence, skin lesions or folds.- prepare the skin at the application site according to facility protocol.If no protocol exists, clip excess hair at application site, clean and disinfect area to remove oils, lotions, etc., and allow to dry thoroughly.- apply the pad firmly to skin, ensuring full adhesion of the pad gel and adhesive, and full pad contact with patient's skin.This issue will continue to be monitored through the complaint system to assure patient safety.
|
|
The user facility reported that during a loop electrosurgical excision procedure, the 51-7810 thermogard burned the patient's left thigh.The injury was found post-operatively and described as "it had blisters and was white and hard." the patient was treated with silvadene cream and covered with telsa non-adhering dressing.The procedure was completed with no other incidents or surgical delays.Upon gathering additional information, the patient was discharged home with no additional hospital stay due to this incident.This report is raised based on a reported patient injury.
|
|
Manufacturer narrative: although the device was not returned for evaluation, photographic evidence and the user facility's clinical engineering service report was provided.This report stated that the used pad was "examined and found that the adhesive on the side of the burn was not as sticky as the opposite side.The gel of the pad was not dried out." the provided photos were evaluated and it was determined that except for one corner, the pad itself did not appear to be damaged from excessive heating, or it being defective; it shows normal wear from being used.Without evaluating and/or functionally testing the pad, we are unable to determine what the discoloration of the one corner of the device might indicate.
|